TAC1 and Alzheimer disease: Thus, following release of proteases by mast cells, cleaved PAR‐2 induces CGRP‐ and substance P–dependent neurogenic inflammation, itch and pain in patients with AD in a manner that also involves signalling via NFκB.68, 71, 72